Approximately 100,000 doses can be manufactured per weekMERIDEN, Conn., June 15 /PRNewswire/ — Protein Sciences Corporation (PSC) announced that today it commenced manufacturing of a vaccine to protect humans against the H1N1 “swine flu” virus. The Company estimates that it can produce 100,000 doses this week and at least 100,000 doses per week thereafter
The vaccine producer Sanofi Aventis stated this week that they will donate 100 million doses of the vaccine against the new H1N1 swine flu to the World Health Organization (WHO) for distribution. The Chief Executive officer for Sanofi, Christopher Viehbacher, stated that the organization can then send the vaccines to the countries that need them most if the decision is made to immunize people against this new strain of flu.
Information on transmission of H1N1 among Health Care Personnel by CDC, reported in MMWR weekly June 19, 2009 / 58(23);641-645: Novel Influenza A (H1N1) Virus Infections Among Health-Care Personnel — United States, April–May 2009 This report was commented on at the very interesting blog “Effect Measure” in a recent post: Swine flu in health care workers: a first look Another interesting source of information is Science Roll. It has this post that I like to share: H1N1 Pandemic Ma
